NEW YORK, Oct. 17 - GeneFormatics has raised $22 million in its third round of financing, the structural proteomics company announced on Wednesday.

Investors supporting the round comprised Bruker AXS, Bruker BioSpin, Bruker Daltonics, TaKaRa Shuzo, and China Development Industrial Bank. They joined earlier investors Perseus-Soros BioPharmaceutical Fund, Merrill Lynch Ventures, Orbimed Advisors, Burrill & Co., GeneChem, Inglewood Ventures, and Moss Forest Venture, GeneFormatics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.